bronchial asthma complicated by COPD and bronchial ashtma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: >COPD (complicated by asthma) or asthma (unquestioned stage) >patients who have inspiratory flow rate can be inhaled test drug >patients who voluntary consent document was obtained after receiving a full explanation upon participation in this study and full understanding >outpatients
Exclusion criteria
Exclusion criteria: >patient wiht an infection refractory to any antibiotics, or deep-seated mycoses >hitory of hypersensitivity to test drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diurnal variation in PEF by Piko-1 | — |
Secondary
| Measure | Time frame |
|---|---|
| expiratory NO eosinophil in sputum serum substance P FEV1.0 FEV1.0 in five minites after inhalaton of Symbicort or Procaterol Hydrochloride chest CT assessment of safty | — |
Countries
Japan
Contacts
Graduate School of Medicine, Chiba University Department of respirology